Stock Track | Tandem Diabetes Care Plummets 5.51% as Citi Downgrades Stock

Stock Track
2025/03/04

Shares of Tandem Diabetes Care (TNDM) plummeted 5.51% in intraday trading on Tuesday, underperforming the broader market. The sell-off came after Citi analyst Joanne Wuensch downgraded the stock to Neutral from Buy.

Wuensch also slashed her price target on TNDM to $24, down from the previous target of $35. The analyst's move to downgrade and lower the price target suggests concerns over the company's prospects and growth outlook.

The downgrade by the influential Wall Street firm has led to increased selling pressure on Tandem Diabetes Care's shares. Investors are likely reassessing their positions and expectations for the medical device company following Citi's bearish stance.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10